Cancer’s Unique
Mutational Fingerprint

Every cancer is unique. We profile each patient’s mutational fingerprint to define the right treatment strategy.

READ MORE

Cancer’s Weakness:
Hiding in Plain Sight

Neoantigens are ideal, untapped targets against cancer.

READ MORE

Advancing in the Clinic

We are a leader in the field of neoantigen-targeted therapies.

READ MORE

Our scientific founders

The leading cancer researchers who founded Neon Therapeutics had a bold vision: To develop a powerful new class of drugs that direct the immune system towards unique targets on tumor cells, called neoantigens. Watch our founders explain this approach.